3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
60
Recruiting
14
Terminated
12
Unknown
6
Active not recruiting
6
Withdrawn
1
Not yet recruiting
1
Enrolling by invitation
1
Available
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
109
Gastrointestinal
14
Breast
10
Thoracic
9
Genitourinary
7
Head & Neck
6
Sarcoma
3
CNS
3
Plasma cell
2
Other solid neoplasm
2
Dermatologic
2
Other hematologic neoplasm
1
Other
1
Myeloid
1
Lymphoid
1
Endocrine
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
65
Lymphoma
59
Lymphoma, Follicular
53
Lymphoma, Large B-Cell, Diffuse
51
Lymphoma, B-Cell
50
Leukemia, Lymphocytic, Chronic, B-Cell
34
Lymphoma, Non-Hodgkin
33
Recurrence
27
Leukemia
22
Lymphoma, Mantle-Cell
20
Burkitt Lymphoma
18
Lymphoma, T-Cell, Peripheral
17
Leukemia, Myeloid, Acute
15
Hodgkin Disease
15
Waldenstrom Macroglobulinemia
14
Hematologic Neoplasms
14
Lymphoma, B-Cell, Marginal Zone
13
Multiple Myeloma
12
Lymphoma, T-Cell, Cutaneous
12
Lymphoma, Extranodal NK-T-Cell
12
Neoplasms
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, B-Cell
8
Motor Activity
7
Myelodysplastic Syndromes
6
Mycosis Fungoides
6
Sezary Syndrome
5
Neoplasm, Residual
5
Pain
4
Neoplasms, Plasma Cell
4
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Ovarian Neoplasms
×
Lymphoid
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled